From this analysis, we identified a cohort of >30 patients with biallelic variants in DIAPH1 exhibiting clinical symptoms consistent with those exhibited by patient P1 i.e., microcephaly, intellectual disability, impaired vision and seizures. This evidence concerns the gene DIAPH1 and microcephaly.